PROM1 and stroke disorder: While the therapeutic effects of CD133 + Exo, EC-Exo, and EPC-Exo on stroke outcome and cardiac function have been previously reported, the effect of CD133 + Exo on the liver function in diabetic stroke mice has not been studied.